64.60
price up icon17.73%   9.5088
 
loading

Crispr Therapeutics Ag Aktie (CRSP) Neueste Nachrichten

pulisher
03:33 AM

What analysts say about CRISPR Therapeutics AG stockConsistently exceptional gains - Jammu Links News

03:33 AM
pulisher
01:01 AM

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares - TipRanks

01:01 AM
pulisher
10:15 AM

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 52-Week High Following Insider Buying Activity - MarketBeat

10:15 AM
pulisher
10:08 AM

Crispr director George buys $51.5M of shares (CRSP:NASDAQ) - Seeking Alpha

10:08 AM
pulisher
09:40 AM

Crispr Therapeutics stock hits 52-week high at 62.32 USD - Investing.com

09:40 AM
pulisher
07:35 AM

Is CRISPR Therapeutics AG a good long term investmentBreakthrough profits - Jammu Links News

07:35 AM
pulisher
Jul 17, 2025

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG! - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jul 17, 2025
pulisher
Jul 16, 2025

CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last? - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Leavell Investment Management Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

William Blair Issues Positive Outlook for CRSP Earnings - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views? - MSN

Jul 16, 2025
pulisher
Jul 15, 2025

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.7%Here's What Happened - MarketBeat

Jul 15, 2025
pulisher
Jul 15, 2025

B & T Capital Management DBA Alpha Capital Management Buys New Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

(CRSP) Trading Report - news.stocktradersdaily.com

Jul 14, 2025
pulisher
Jul 14, 2025

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade) - Seeking Alpha

Jul 14, 2025
pulisher
Jul 12, 2025

Crispr Therapeutics AG Stock Soars Amid Strategic Moves - TipRanks

Jul 12, 2025
pulisher
Jul 12, 2025

CRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech Rally - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

CRISPR Therapeutics Target of Unusually Large Options Trading (NASDAQ:CRSP) - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com

Jul 11, 2025
pulisher
Jul 11, 2025

Genome Engineering Market Booming as CRISPR and Gene Editing - openPR.com

Jul 11, 2025
pulisher
Jul 11, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Shares Up 7%Should You Buy? - MarketBeat

Jul 11, 2025
pulisher
Jul 10, 2025

CRISPR Stock Surges in Recent Weeks: What's Going On?CRISPR Therapeutics (NASDAQ:CRSP) - Benzinga

Jul 10, 2025
pulisher
Jul 09, 2025

10 Stocks Going Wild - Insider Monkey

Jul 09, 2025
pulisher
Jul 09, 2025

CRISPR’s Medical Breakthrough: Stock Surge or Mirage? - StocksToTrade

Jul 09, 2025
pulisher
Jul 09, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial Results - Yahoo Finance

Jul 09, 2025
pulisher
Jul 09, 2025

CRISPR Therapeutics Rises Amid Positive Cardiovascular Trials - timothysykes.com

Jul 09, 2025
pulisher
Jul 09, 2025

CRISPR Therapeutics’ Bold Leap: A Revolution in Cardiovascular Treatment? - StocksToTrade

Jul 09, 2025
pulisher
Jul 08, 2025

CRISPR Therapeutics Reports Landmark Advances in Cardiovascular Trials - timothysykes.com

Jul 08, 2025
pulisher
Jul 08, 2025

Crispr Therapeutics AG: Strategic Positioning and Growth Potential in Gene Editing - TipRanks

Jul 08, 2025
pulisher
Jul 08, 2025

Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader Market - MSN

Jul 08, 2025
pulisher
Jul 07, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Boosted by Cambridge Investment Research Advisors Inc. - MarketBeat

Jul 07, 2025
pulisher
Jul 07, 2025

CRISPR Therapeutics’ SWOT analysis: gene-editing pioneer’s stock faces pivotal year - Investing.com

Jul 07, 2025
pulisher
Jul 05, 2025

Crispr Therapeutics AG Stock Soars Amid Clinical Advances - TipRanks

Jul 05, 2025
pulisher
Jul 03, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 7.1%Here's Why - MarketBeat

Jul 03, 2025
pulisher
Jul 01, 2025

Wealth Enhancement Advisory Services LLC Boosts Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 01, 2025
pulisher
Jun 30, 2025

CRISPR Therapeutics AG(NasdaqGM: CRSP) added to Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Crispr Therapeutics’ Stock Surges on Promising Study Update - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - MSN

Jun 30, 2025
pulisher
Jun 28, 2025

Brookline Capital Markets Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail

Jun 28, 2025
pulisher
Jun 27, 2025

Goldman Sachs Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and Mail

Jun 27, 2025
pulisher
Jun 27, 2025

Crispr Therapeutics downgraded to Hold from Buy at Clear Street - TipRanks

Jun 27, 2025
pulisher
Jun 27, 2025

Is CRISPR Therapeutics (CRSP) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing - MSN

Jun 26, 2025
pulisher
Jun 26, 2025

CRISPR Therapeutics Reports Positive Additional Phase 1 - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

CRISPR Therapeutics (CRSP) Reports Positive Additional Phase 1 Data for CTX310 Targeting ANGPTL3 - StreetInsider

Jun 26, 2025
pulisher
Jun 26, 2025

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline - GlobeNewswire

Jun 26, 2025
pulisher
Jun 26, 2025

CRISPR Breakthrough: New Drug Slashes Heart Disease Risk with 86% Cholesterol Reduction in Clinical Trial - Stock Titan

Jun 26, 2025
pulisher
Jun 25, 2025

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential? - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

CRISPR Therapeutics AG (CRSP): A Bull Case Theory - Yahoo Finance

Jun 24, 2025
pulisher
Jun 21, 2025

Crispr Therapeutics: Face The Harsh Reality Instead Of Waiting (Rating Downgrade) - Seeking Alpha

Jun 21, 2025
$22.19
price up icon 0.86%
$35.45
price up icon 0.37%
$104.57
price up icon 0.51%
$27.95
price up icon 1.07%
$110.73
price down icon 0.10%
biotechnology ONC
$298.88
price up icon 3.15%
Kapitalisierung:     |  Volumen (24h):